Justin Walsh
Stock Analyst at Jones Trading
(3.25)
# 1,046
Out of 5,148 analysts
40
Total ratings
38.89%
Success rate
22.38%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMTC NeuroOne Medical Technologies | Initiates: Buy | $1.5 | $0.67 | +124.89% | 1 | Mar 2, 2026 | |
| LNTH Lantheus Holdings | Downgrades: Hold | n/a | $76.30 | - | 11 | Feb 27, 2026 | |
| ATAI AtaiBeckley | Initiates: Buy | $16 | $3.68 | +334.78% | 1 | Dec 23, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $83 | $330.59 | -74.89% | 1 | Sep 18, 2025 | |
| VNRX VolitionRx | Initiates: Buy | $3 | $0.20 | +1,380.02% | 1 | Jun 10, 2025 | |
| BLRX BioLineRx | Upgrades: Buy | $12 | $2.86 | +319.58% | 3 | May 30, 2025 | |
| CLNN Clene | Initiates: Buy | $30 | $5.24 | +472.52% | 1 | Apr 23, 2025 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $53.47 | - | 1 | Apr 2, 2025 | |
| SER Serina Therapeutics | Initiates: Buy | $11 | $1.77 | +521.47% | 1 | Mar 11, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $18 | $20.63 | -12.75% | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $28.37 | +48.04% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $5.35 | +311.21% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.01 | +219.36% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.62 | +332.90% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $4 | $0.75 | +434.05% | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.66 | +329.18% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $360 | $15.90 | +2,164.15% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $440 | $0.77 | +57,288.81% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $0.30 | +24,933.38% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $53.59 | -62.68% | 1 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $440 → $200 | $1.08 | +18,418.52% | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $5.68 | +76.06% | 1 | Jan 19, 2022 |
NeuroOne Medical Technologies
Mar 2, 2026
Initiates: Buy
Price Target: $1.5
Current: $0.67
Upside: +124.89%
Lantheus Holdings
Feb 27, 2026
Downgrades: Hold
Price Target: n/a
Current: $76.30
Upside: -
AtaiBeckley
Dec 23, 2025
Initiates: Buy
Price Target: $16
Current: $3.68
Upside: +334.78%
Praxis Precision Medicines
Sep 18, 2025
Initiates: Buy
Price Target: $83
Current: $330.59
Upside: -74.89%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $3
Current: $0.20
Upside: +1,380.02%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $2.86
Upside: +319.58%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $5.24
Upside: +472.52%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $53.47
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $1.77
Upside: +521.47%
Alto Neuroscience
Dec 16, 2024
Initiates: Buy
Price Target: $18
Current: $20.63
Upside: -12.75%
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $28.37
Upside: +48.04%
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $5.35
Upside: +311.21%
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $5.01
Upside: +219.36%
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $4.62
Upside: +332.90%
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $0.75
Upside: +434.05%
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $4.66
Upside: +329.18%
May 16, 2023
Initiates: Buy
Price Target: $360
Current: $15.90
Upside: +2,164.15%
Feb 10, 2023
Initiates: Buy
Price Target: $440
Current: $0.77
Upside: +57,288.81%
Oct 7, 2022
Initiates: Buy
Price Target: $75
Current: $0.30
Upside: +24,933.38%
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $53.59
Upside: -62.68%
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $1.08
Upside: +18,418.52%
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $5.68
Upside: +76.06%